Comparison of 30-day Morbidity and Mortality in Cancer Patients Based on Emergency Department Location
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Cancer, Cancer Remission. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of 30-day Morbidity and Mortality in Cancer Patients Based on Emergency Department Location: Referring Oncology Hospital vs Other Hospitals.
Overview
Patients being followed for cancer account for 2.8% of emergency admissions in France. An acute episode that triggers a visit to the emergency department may be related to the progression of the disease, or to complications of treatment. The management of these patients is often complex and requires a degree of expertise. Emergency departments specialising in the management of cancer complications have been set up, and now deal exclusively with patients treated at their centres. However, for geographical or logistical reasons, patients with cancer are likely to consult a non-specialist emergency department and/or one located outside the cancer care centre. In this case, the emergency doctor may not have access to the oncology file, and care in the emergency department and downstream services may be sub-optimal. Studies have shown a positive impact on the quality of care and prognosis of patients thanks to the cancer centre's expertise. However, the effect of the centre on a cancer patient who visits the emergency department has never been studied. This is particularly true if the emergency department where the patient is seen is located in the cancer follow-up centre. The primary objective of the COVER study is to investigate the impact of the location of the emergency department where the patient is seen for their prognosis.
Primary outcome measures
- Number of days alive spent outside the hospital [Time frame: 1 month]
Secondary outcome measures (9)
- Occurrence of a new/ unscheduled consultation [Time frame: 30 days]
- Length of hospitalisation [Time frame: 90 day]
- Unscheduled consultation or hospitalization emergency department discharge [Time frame: 7 days]
- Unexpected death [Time frame: 7 days]
- Secondary admission to the intensive care unit during the initial hospitalization following the emergency visit [Time frame: 7 days]
- Occurence of organ failure [Time frame: 7 days]
- Quality of life with QLQ-C30 [Time frame: 90 days]
- Mortality [Time frame: 30 days]
- Mortality [Time frame: Day 90]
Eligibility criteria
Inclusion criteria
Patients aged 18 or over admitted to an emergency department with cancer that has been active or in remission for less than a year.
Exclusion criteria
\- Opposition to participate in the study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Hôpital Pitié Salpêtrière Emergency department — Paris
Identifiers
NCT: NCT06834646 · APHP240971 · IDRCB: 2024-A01679-38